Using SMD alone to screen older patients for geriatric assessment requires improvement. High-sensitivity cut-off points could miss 11-24% of patients with frailty, and many non-frail patients may be flagged. Screening with SMD is practical but work is needed to understand clinical andresource impacts of different cut-off points. Future research should evaluate performance with additional clinical data and in subgroups.
Keyphrases
- skeletal muscle
- end stage renal disease
- ejection fraction
- healthcare
- type diabetes
- community dwelling
- newly diagnosed
- chronic kidney disease
- cardiovascular disease
- physical activity
- palliative care
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- insulin resistance
- high throughput
- machine learning
- quality improvement
- squamous cell carcinoma
- metabolic syndrome
- patient reported outcomes
- squamous cell
- young adults
- patient reported
- single cell
- lymph node metastasis
- affordable care act
- weight loss
- childhood cancer